CD8A and COVID-19: Within anti-TNF-α-treated patients, COVID-19 asymptomatic subjects had a trend to higher CD8+ total memory GZMB/K+, memory, and class-switched B cells, while TH1 and CD8+ CD27+ GZMB/K+ cells were comparable in symptomatic and asymptomatic subjects (Supplementary Figures 8A–C).